The authors of this Viewpoint discuss the protective activity of fenretinide on second breast cancer as a surrogate marker of primary prevention and the possibility of using this agent in young women bearing germlineBRCA-1 and BRCA-2mutations.
- Andrea Decensi
- Silvia Zanardi
- Umberto Veronesi